Biocon Limited Share Price Falls 1.51% (Sep 7, 2026)

Biocon Limited

BIOCON.NS

₹391.40

▼ 1.51%

Biocon eased 1.51% to ₹391.40 in the absence of any specific news catalyst. Its longer-term trend has been positive but unspectacular, with a 7.50% CAGR over one year and single-digit returns of 2.34% and 1.87% over two and five years respectively, alongside a steadier 9.67% CAGR over a decade. Nineteen analysts tracking the stock maintain a buy consensus, and their average target of ₹446.89 stands well above the current market price.

CAGR Performance

1 Year	2 Years	5 Years	10 Years
9.16%	2.65%	2.44%	10.14%

Analyst Consensus

Average Target Price: ₹446.89 (range ₹326.00 - ₹534.00) based on 19 analysts

Strong Buy: 1 Buy: 8 Hold: 3 Sell: 2 Strong Sell: 4

View Biocon Limited full details, charts & financials →

Related News

Sep 4, 2026	Biocon Limited Share Price Jumps 0.30% (Sep 3, 2026)
Aug 18, 2026	Biocon Announces U.S. FDA Approval For Yesintek Single-Dose Prefilled Autoinjector
Aug 13, 2026	Biocon Limited Share Price Falls 2.55% Today (Aug 13, 2026)